Suppr超能文献

抗生素治疗对囊性纤维化小鼠脂肪吸收的影响。

Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis.

机构信息

Department of Pediatrics, Beatrix Children's Hospital-University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Pediatr Res. 2012 Jan;71(1):4-12. doi: 10.1038/pr.2011.4.

Abstract

INTRODUCTION

Improving fat absorption remains a challenge in cystic fibrosis (CF). Antibiotics (AB) treatment has been shown to improve body weight in CF mice. The mechanism may include improvement in fat absorption. We aimed to determine the effect of AB on fat absorption in two CF mouse models.

RESULTS

AB did not improve total fat absorption. Interestingly, AB accelerated the absorption of isotope-labeled fats, in both Δ/Δ and WT mice. The changes observed were not related to the solubilization capacity of bile or to changes in the bacteria in the small intestine. AB reduced the fecal excretion of cholate by ~50% (P < 0.05) in both CF mouse models, indicating improved intestinal bile salt absorption.

DISCUSSION

In conclusion, AB treatment does not improve total fat absorption in CF mice but does decrease fecal loss of bile salts and accelerate long-chain fatty acid (LCFA) absorption.

METHODS

For 3 weeks, we administered oral AB (ciprofloxacin/metronidazole) or control treatment to homozygous ΔF508 (Δ/Δ), cystic fibrosis transmembrane conductance regulator (CFTR) knockout (-/-), and wild-type (WT) mice and quantified fat absorption using a 72-h fat balance test. In Δ/Δ mice, we assessed fat absorption kinetics by administering tri-1-(13)C-palmitin and 1-(13)C-stearate intragastrically and determining the appearance of stable isotope-labeled fats in plasma. We quantified biliary and fecal bile salts (gas chromatography) and small intestinal bacteria (quantitative-PCR).

摘要

简介

提高脂肪吸收能力仍然是囊性纤维化(CF)的一个挑战。抗生素(AB)治疗已被证明可改善 CF 小鼠的体重。其机制可能包括改善脂肪吸收。我们旨在确定 AB 对两种 CF 小鼠模型中脂肪吸收的影响。

结果

AB 并未改善总脂肪吸收。有趣的是,AB 加速了 Δ/Δ 和 WT 小鼠中同位素标记脂肪的吸收。观察到的变化与胆汁的溶解能力或小肠内细菌的变化无关。AB 减少了 CF 小鼠模型中胆酸盐的粪便排泄量约 50%(P < 0.05),表明改善了肠道胆盐吸收。

讨论

总之,AB 治疗并未改善 CF 小鼠的总脂肪吸收,但可减少胆汁盐的粪便丢失并加速长链脂肪酸(LCFA)的吸收。

方法

我们对纯合子 ΔF508(Δ/Δ)、囊性纤维化跨膜电导调节因子(CFTR)敲除(-/-)和野生型(WT)小鼠进行了 3 周的口服 AB(环丙沙星/甲硝唑)或对照治疗,并使用 72 小时脂肪平衡试验量化了脂肪吸收。在 Δ/Δ 小鼠中,我们通过胃内给予三-1-(13)C-棕榈酸和 1-(13)C-硬脂酸,并确定稳定同位素标记脂肪在血浆中的出现来评估脂肪吸收动力学。我们量化了胆汁和粪便中的胆汁盐(气相色谱法)和小肠细菌(定量 PCR)。

相似文献

引用本文的文献

1
Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.囊性纤维化小鼠肠道法尼醇 X 受体信号转导受损。
Cell Mol Gastroenterol Hepatol. 2020;9(1):47-60. doi: 10.1016/j.jcmgh.2019.08.006. Epub 2019 Aug 27.
2
Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis.成人囊性纤维化患者的粪便失禁患病率。
Dig Dis Sci. 2018 Apr;63(4):982-988. doi: 10.1007/s10620-017-4825-2. Epub 2017 Oct 30.
6
Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice.脂肪从头合成的改变导致囊性纤维化小鼠脂肪储存减少。
Am J Physiol Gastrointest Liver Physiol. 2012 Aug 15;303(4):G507-18. doi: 10.1152/ajpgi.00451.2011. Epub 2012 Jun 7.

本文引用的文献

3
Small intestinal bacterial overgrowth.小肠细菌过度生长
Scand J Gastroenterol. 2008;43(9):1030-7. doi: 10.1080/00365520801947074.
6
Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine.囊性纤维化小鼠小肠的转运改变与细菌过度生长
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G104-11. doi: 10.1152/ajpgi.00548.2006. Epub 2007 Mar 15.
8
Gastrointestinal outcomes and confounders in cystic fibrosis.囊性纤维化的胃肠道结局与混杂因素
J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):273-85. doi: 10.1097/01.mpg.0000178439.64675.8d.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验